We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+6.34%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$3.49B
AUM Growth
+$69M
Cap. Flow
-$61.4M
Cap. Flow %
-1.76%
Top 10 Hldgs %
14.53%
Holding
252
New
41
Increased
84
Reduced
93
Closed
21

Top Buys

Rank Stock Value
1
SPNC
Spectranetics Corp
SPNC
+$20.1M
2
ABCO
Advisory Board Co
ABCO
+$19.7M
3
AZTA icon
Azenta
AZTA
+$18.7M
4
DWRE
DEMANDWARE INC COM STK (DE)
DWRE
+$17M
5
ESPR
Esperion Therapeutics
ESPR
+$15M

Top Sells

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$46.6M
2
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$27.9M
3
ALKS icon
Alkermes
ALKS
+$27.5M
4
RVBD
RIVERBED TECHNOLOGY, INC COM
RVBD
+$18.7M
5
NKTR icon
Nektar Therapeutics
NKTR
+$17.7M

Sector Composition

Rank Sector Weight
1 Technology 31.21%
2 Healthcare 15.87%
3 Industrials 14.84%
4 Consumer Discretionary 10.82%
5 Communication Services 4.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENV
201
DELISTED
ENVESTNET, INC.
ENV
$3.05M 0.09%
54,382
– –
DSGR icon
202
Distribution Solutions Group
DSGR
$1.61B
$3M 0.09%
+258,200
New +$3.28M
MMYT icon
203
MakeMyTrip
MMYT
$5.8B
$2.8M 0.08%
+127,400
New +$3.1M
MNTX
204
DELISTED
Manitex International, Inc.
MNTX
$2.72M 0.08%
279,591
+81,157
+41% +$882K
LJPC
205
DELISTED
La Jolla Pharmaceutical Company
LJPC
$2.59M 0.07%
141,647
-52,931
-27% -$1.07M
HDSN
206
Hudson Technologies
HDSN
$239M
$2.56M 0.07%
+614,168
New +$2.34M
JMBA
207
DELISTED
Jamba, Inc.
JMBA
$2.53M 0.07%
+171,900
New +$2.63M
PRTK
208
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$2.36M 0.07%
+75,486
New +$2.17M
DMRC icon
209
Digimarc Corp
DMRC
$168M
$2.34M 0.07%
+106,763
New +$2.72M
HPTX
210
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$2.27M 0.06%
+49,400
New +$1.48M
KEG
211
DELISTED
KEY ENERGY SERVICES INC
KEG
$2.21M 0.06%
1,216,460
+659,660
+118% +$1.2M
DSCI
212
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$2.1M 0.06%
247,520
-81,682
-25% -$696K
DFRG
213
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
$2.09M 0.06%
103,550
-103,550
-50% -$2.08M
DKS icon
214
Dick's Sporting Goods
DKS
$19.1B
$1.87M 0.05%
32,800
-282,075
-90% -$15.5M
ANF icon
215
Abercrombie & Fitch
ANF
$5.23B
$1.81M 0.05%
82,000
-179,800
-69% -$4.43M
DARE icon
216
Dare Bioscience
DARE
$21M
$1.73M 0.05%
+1,598
New +$1.55M
BAS
217
DELISTED
Basis Energy Services, Inc.
BAS
$1.7M 0.05%
430
– –
AGRX
218
DELISTED
Agile Therapeutics
AGRX
$1.69M 0.05%
+91
New +$1.59M
SGMO
219
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.5M 0.04%
+95,400
New +$1.48M
CSOD
220
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$1.46M 0.04%
50,400
-74,700
-60% -$2.44M
BDSI
221
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.44M 0.04%
136,925
-4,440
-3% -$60.7K
SAUC
222
DELISTED
Diversified Restaurant Holdings, Inc. Common stock
SAUC
$1.3M 0.04%
310,365
-85,515
-22% -$402K
PRTA icon
223
Prothena Corp
PRTA
$442M
$1.29M 0.04%
33,894
– –
SPA
224
DELISTED
Sparton
SPA
$1.12M 0.03%
45,834
-17,305
-27% -$415K
BSTG
225
DELISTED
Biostage, Inc. Common Stock
BSTG
$1.06M 0.03%
325,929
-22,955
-7% -$78.2K
7 8
9
10 11

Similar funds

HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

Granahan Investment Management's Q1 2015 Portfolio in Review

As of Q1 2015, Granahan Investment Management held 252 positions worth $3.49B, up 2% from $3.43B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Granahan Investment Management's Q1 2015 filing shows 41 new, 84 increased, 93 reduced and 21 closed positions. Its largest new stake was Spectranetics Corp: 592,000 shares worth $20.6M. The largest sale was PTC Therapeutics, an estimated $46.6M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.

  • Granahan Investment Management's largest Q1 2015 buy was Spectranetics Corp: 592,000 shares worth $20.6M.
  • Granahan Investment Management added most to Advisory Board Co in Q1 2015, an estimated $19.7M increase.
  • Granahan Investment Management's biggest Q1 2015 reduction was PTC Therapeutics, cutting an estimated $46.6M.
  • Granahan Investment Management fully exited AUXILIUM PHARAMCEUTICALS INC in Q1 2015, selling an estimated $27.9M.
  • Granahan Investment Management's ten largest holdings make up 15% of its $3.49B portfolio in Q1 2015.
  • Granahan Investment Management opened 41 new positions and closed 21 in Q1 2015.
  • Granahan Investment Management's portfolio value rose 2% quarter-over-quarter to $3.49B.

Based on Granahan Investment Management's 13F filing for Q1 2015, filed 10 Apr 2015.